Versa Vascular vs XCath
Versa Vascular vs XCath, compared side by side on 17 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Versa Vascular is on 53/100 and XCath on 54/100.
Where each one leads
Versa Vascular
- domain rating: 15/100 against 12/100
XCath
- funding raised: $54.0M against $15.0M
At a glance
| Measure | Versa Vascular | XCath |
|---|---|---|
| What it is | Developing innovative, minimally invasive solutions for tricuspid valve disease treatment. | Pioneering neuro-endovascular surgical robotics for precise, remote-controlled treatment of brain aneurysms and strokes. |
| Category | Medical Devices, HealthTech, Biotechnology, MedTech | Medical Devices, Robotics, Healthcare, Biotechnology |
| Sells toBusiness model | B2B | B2B |
| Offering | Hardware | Hardware |
| Founded | 2017 | 2017 |
| Headquarters | Santa Cruz, United States | Houston, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Versa Vascular | XCath |
|---|---|---|
| Employees | Not published | 31 |
| Total funding | $15.0M | $54.0M |
| Latest round | Series C | Series C |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Versa Vascular | XCath |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 53/100 | 54/100 |
| Traction | 36/100 | 54/100 |
| Team | 50/100 | 30/100 |
| Search visibility | Not published | 9/100 |
| Quality | 68/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (41/100) |
| Domain ratingLink authority, 0-100 | 15/100 | 12/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Versa Vascular | XCath |
|---|---|---|
| CDN | Cloudflare | Fastly |
| CMS | WordPress | Not detected |
| Frameworks | Jquery | Jquery, Tailwind CSS, Bootstrap |
Versa Vascular vs XCath: common questions
Which is better, Versa Vascular or XCath?
On our 0-100 score XCath rates higher (54/100 against 53/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 17 data points above: read the rows that match what you are buying for.
How do Versa Vascular and XCath compare on the numbers?
Versa Vascular leads on domain rating (15/100 against 12/100). XCath leads on funding raised ($54.0M against $15.0M).
Read the full Versa Vascular review and pricing or the XCath review and pricing. You can also browse other Versa Vascular alternatives we track.